Guozhi Liang
Papers
1
Total Citations
10
H-Index
1
About
Dr. Guozhi Liang is a leading hepatobiliary surgeon whose research focuses on advancing minimally invasive surgical techniques for hepatocellular carcinoma (HCC), particularly in anatomically challenging liver segments. His most cited work provides critical comparative evidence on the safety and efficacy of open, laparoscopic, and robotic hepatectomy for BCLC stage 0-A HCC located in segments 7 and 8—traditionally difficult-to-access areas of the liver. Through a rigorous propensity-matched analysis, Dr. Liang demonstrated that both laparoscopic and robotic approaches offer favorable perioperative outcomes compared to open surgery, including reduced blood loss and shorter hospital stays, without compromising oncologic efficacy. This study, already garnering 10 citations shortly after its 2025 publication, has helped guide surgical decision-making for complex liver resections. Dr. Liang’s contributions are particularly impactful in establishing robotic hepatectomy as a viable and potentially superior option for posterior-superior segment tumors, expanding the boundaries of minimally invasive liver surgery. His work continues to shape clinical practice by providing evidence-based comparisons that help surgeons select the optimal approach for individual patients, ultimately improving recovery and outcomes in HCC treatment.
Research Focus
Key Achievements
Top Papers
- 1